by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
–SUNRISE Top-line Data Accepted for Late-Breaking Oral Presentation at European Society of Medical Oncology Congress in October 2016 — — Avid First Quarter Revenue of $5.6 Million with Over $20 Million in Revenue Projected in Second Quarter —...
by GlobeNewsWire | Sep 6, 2016 | Globe Newswire
TUSTIN, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) — Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies...
by GlobeNewsWire | Aug 18, 2016 | Globe Newswire
MEDFORD, N.Y., Aug. 18, 2016 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, today announced that the Company has entered into an exclusive distribution agreement with Isla Lab...
by GlobeNewsWire | Aug 11, 2016 | Globe Newswire
MEDFORD, N.Y., Aug. 11, 2016 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (“POC”) diagnostic tests for infectious diseases, today reported financial results for the three and six months ended June 30, 2016. John J....
by GlobeNewsWire | Aug 8, 2016 | Globe Newswire
WACO, Texas, Aug. 08, 2016 (GLOBE NEWSWIRE) — H. Thomas Moran, II, Chapter 11 Trustee for Life Partners Holdings Inc. (LPHI), is clarifying for LPHI creditors that the “Investor Plan” proposed by Moran and the Official Committee of Unsecured Creditors in the...